<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9247567" created="01/06/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9247567</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="cyclosporin_A" sem="Organic_compound_other">Cyclosporin A</term> interferes with the inducible degradation of <term id="T2" lex="NF-kappa_B_inhibitor" sem="Organic_compound_other"><term id="T3" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> inhibitors</term>, but not with the processing of <term id="A4" sem="Protein_molecule">p105/<term id="T4" lex="NF-kappa_B1" sem="Protein_complex">NF-kappa B1</term></term> in <term id="T5" lex="T_cell" sem="Cell_natural">T cells</term>.</sentence>
<event id="E1">
<type class="Negative_regulation"/>
<theme idref="E2"/>
<cause idref="T1"/>
<clue>Cyclosporin A <clueType>interferes</clueType> <linkTheme>with</linkTheme> the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 <clueLoc>in T cells</clueLoc>.</clue>
</event>
<event id="E2">
<type class="Protein_catabolism"/>
<theme idref="T3"/>
<clue>Cyclosporin A interferes with the inducible <clueType>degradation</clueType> <linkTheme>of</linkTheme> NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E3">
<type class="Negative_regulation"/>
<theme idref="E4"/>
<cause idref="T1"/>
<clue>Cyclosporin A <clueType>interferes</clueType> with the inducible degradation of NF-kappa B inhibitors, but <cluePolarity>not</cluePolarity> <linkTheme>with</linkTheme> the processing of p105/NF-kappa B1 <clueLoc>in T cells</clueLoc>.</clue>
</event>
<event id="E4">
<type class="Protein_processing"/>
<theme idref="A4"/>
<clue>Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the <clueType>processing</clueType> <linkTheme>of</linkTheme> p105/NF-kappa B1 in T cells.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term id="T6" lex="transcription_factor" sem="Protein_family_or_group">transcription factor</term> <term id="T7" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> controls the induction of numerous <term id="T8" lex="cytokine_promoter" sem="DNA_family_or_group">cytokine promoters</term> during the activation of <term id="T9" lex="T_lymphocyte" sem="Cell_natural">T lymphocytes</term>.</sentence>
<event KT="Fact" id="E5">
<type class="Regulation"/>
<theme idref="E6"/>
<cause idref="T7"/>
<clue>The transcription factor NF-kappa B <clueType>controls</clueType> the induction of numerous cytokine promoters during the activation of <clueLoc>T lymphocytes</clueLoc>.</clue>
</event>
<event KT="Other" id="E6">
<type class="Positive_regulation"/>
<theme idref="T8"/>
<clue>The transcription factor NF-kappa B controls the <clueType>induction</clueType> <linkTheme>of</linkTheme> numerous cytokine promoters <clueTime>during the activation of T lymphocytes</clueTime>.</clue>
</event>
<event KT="Other" id="E7">
<type class="Physiological_process"/>
<theme idref="T9"/>
<clue>The transcription factor NF-kappa B controls the induction of numerous cytokine promoters during the <clueType>activation</clueType> <linkTheme>of</linkTheme> T lymphocytes.</clue>
</event>
<sentence id="S3">Inhibition of <term id="T10" lex="T_cell_activation" sem="Other"><term id="A1" sem="Cell_natural">T cell</term> activation</term> by the <term id="T11" lex="immunosuppressant" sem="Organic_compound_other">immunosuppressants</term> <term id="T12" lex="cyclosporin_A" sem="Organic_compound_other">cyclosporin A</term> (<term id="T13" lex="CsA" sem="Organic_compound_other">CsA</term>) and <term id="T14" lex="FK506" sem="Organic_compound_other">FK506</term> exerts a suppressive effect on the induction of these <term id="T15" lex="NF-kappa_B-controlled_cytokine_promoter" sem="DNA_family_or_group"><term id="T16" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>-controlled <term id="T17" lex="cytokine_promoter" sem="DNA_family_or_group">cytokine promoters</term></term>.</sentence>
<event KT="Other" id="E8">
<type class="Physiological_process"/>
<theme idref="A1"/>
<clue>Inhibition of T cell <clueType>activation</clueType> by the immunosuppressants cyclosporin A (CsA) and FK506 exerts a suppressive effect on the induction of these NF-kappa B-controlled cytokine promoters.</clue>
</event>
<event KT="Other" id="E9">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<cause idref="T13"/>
<clue><clueType>Inhibition</clueType> of T cell activation <linkCause>by</linkCause> the immunosuppressants cyclosporin A (CsA) and FK506 exerts a suppressive effect on the induction of these NF-kappa B-controlled cytokine promoters.</clue>
</event>
<event KT="Other" id="E14">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<cause idref="T14"/>
<clue><clueType>Inhibition</clueType> of T cell activation <linkCause>by</linkCause> the immunosuppressants cyclosporin A (CsA) and FK506 exerts a suppressive effect on the induction of these NF-kappa B-controlled cytokine promoters.</clue>
</event>
<event KT="Fact" id="E10">
<type class="Negative_regulation"/>
<theme idref="E12"/>
<cause idref="E9"/>
<clue>Inhibition of T cell activation by the immunosuppressants cyclosporin A (CsA) and FK506 <clueType>exerts a suppressive effect</clueType> <linkTheme>on</linkTheme> the induction of these NF-kappa B-controlled cytokine promoters.</clue>
</event>
<event KT="Fact" id="E11">
<type class="Negative_regulation"/>
<theme idref="E12"/>
<cause idref="E14"/>
<clue>Inhibition of T cell activation by the immunosuppressants cyclosporin A (CsA) and FK506 <clueType>exerts a suppressive effect</clueType> <linkTheme>on</linkTheme> the induction of these NF-kappa B-controlled cytokine promoters.</clue>
</event>
<event KT="Other" id="E12">
<type class="Positive_regulation"/>
<theme idref="T15"/>
<clue>Inhibition of T cell activation by the immunosuppressants cyclosporin A (CsA) and FK506 exerts a suppressive effect on the <clueType>induction</clueType> <linkTheme>of</linkTheme> these NF-kappa B-controlled cytokine promoters.</clue>
</event>
<event KT="Other" id="E13">
<type class="Regulation"/>
<theme idref="T17"/>
<cause idref="T16"/>
<clue>Inhibition of T cell activation by the immunosuppressants cyclosporin A (CsA) and FK506 exerts a suppressive effect on the induction of these NF-kappa B-<clueType>controlled</clueType> cytokine promoters.</clue>
</event>
<sentence id="S4">We show for <term id="T18" lex="human_Jurkat_T_leukemia_cell" sem="Cell_cultured">human Jurkat T leukemia cells</term>, as well as <cons id="T19" lex="(AND human_primary_T_lymphocyte mouse_primary_T_lymphocyte)" sem="(AND Cell_natural Cell_natural)"><frag id="F1">human</frag> and <frag id="F2">mouse</frag> <frag id="F3">primary T lymphocytes</frag></cons>, that this inhibitory effect is accompanied by an impaired nuclear translocation of the <term id="T20" lex="Rel_protein" sem="Protein_family_or_group">Rel proteins</term> <term id="T21" lex="c-Rel" sem="Protein_molecule">c-Rel</term>, <term id="T22" lex="RelA/p65" sem="Protein_molecule">RelA/p65</term> and <term id="T23" lex="NF-kappa_B1/p50" sem="Protein_molecule">NF-kappa B1/p50</term>, whereas the nuclear appearance of <term id="T24" lex="RelB" sem="Protein_molecule">RelB</term> remains unaffected.</sentence>
<event KT="Analysis" id="E15">
<type class="Correlation"/>
<theme idref="E10"/>
<theme idref="E24"/>
<clue>We <clueKT>show</clueKT> for <clueLoc>human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes</clueLoc>, that <corefTheme idref1="E10">this inhibitory effect</corefTheme> is <clueType>accompanied</clueType> <linkTheme>by</linkTheme> an impaired nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
<comment>EXP</comment></event>
<event KT="Analysis" id="E16">
<type class="Correlation"/>
<theme idref="E10"/>
<theme idref="E25"/>
<clue>We <clueKT>show</clueKT> for <clueLoc>human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes</clueLoc>, that <corefTheme idref1="E10">this inhibitory effect</corefTheme> is <clueType>accompanied</clueType> <linkTheme>by</linkTheme> an impaired nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
<comment>EXP</comment></event>
<event KT="Analysis" id="E17">
<type class="Correlation"/>
<theme idref="E10"/>
<theme idref="E26"/>
<clue>We <clueKT>show</clueKT> for <clueLoc>human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes</clueLoc>, that <corefTheme idref1="E10">this inhibitory effect</corefTheme> is <clueType>accompanied</clueType> <linkTheme>by</linkTheme> an impaired nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
<comment>EXP</comment></event>
<event KT="Analysis" id="E18">
<type class="Correlation"/>
<theme idref="E11"/>
<theme idref="E24"/>
<clue>We <clueKT>show</clueKT> for <clueLoc>human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes</clueLoc>, that <corefTheme idref1="E11">this inhibitory effect</corefTheme> is <clueType>accompanied</clueType> <linkTheme>by</linkTheme> an impaired nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
<comment>EXP</comment></event>
<event KT="Analysis" id="E19">
<type class="Correlation"/>
<theme idref="E11"/>
<theme idref="E25"/>
<clue>We <clueKT>show</clueKT> for <clueLoc>human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes</clueLoc>, that <corefTheme idref1="E11">this inhibitory effect</corefTheme> is <clueType>accompanied</clueType> <linkTheme>by</linkTheme> an impaired nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
<comment>EXP</comment></event>
<event KT="Analysis" id="E20">
<type class="Correlation"/>
<theme idref="E11"/>
<theme idref="E26"/>
<clue>We <clueKT>show</clueKT> for <clueLoc>human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes</clueLoc>, that <corefTheme idref1="E11">this inhibitory effect</corefTheme> is <clueType>accompanied</clueType> <linkTheme>by</linkTheme> an impaired nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
<comment>EXP</comment></event>
<event KT="Other" id="E21">
<type class="Localization"/>
<theme idref="T21"/>
<clue>We show for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an impaired <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
</event>
<event KT="Other" id="E22">
<type class="Localization"/>
<theme idref="T22"/>
<clue>We show for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an impaired <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
</event>
<event KT="Other" id="E23">
<type class="Localization"/>
<theme idref="T23"/>
<clue>We show for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an impaired <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
</event>
<event KT="Other" id="E24">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<clue>We show for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an <clueType>impaired</clueType> nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
</event>
<event KT="Other" id="E25">
<type class="Negative_regulation"/>
<theme idref="E22"/>
<clue>We show for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an <clueType>impaired</clueType> nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
</event>
<event KT="Other" id="E26">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<clue>We show for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an <clueType>impaired</clueType> nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E27">
<type class="Negative_regulation"/>
<theme idref="E28"/>
<clue>We <clueKT>show</clueKT> for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an impaired nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains <clueType><cluePolarity>unaffected</cluePolarity></clueType>.</clue>
</event>
<event KT="Other" id="E28">
<type class="Localization"/>
<theme idref="T24"/>
<clue>We show for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an impaired nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the <clueLoc>nuclear</clueLoc> <clueType>appearance</clueType> <linkTheme>of</linkTheme> RelB remains unaffected.</clue>
</event>
<sentence id="S5"><term id="T25" lex="CsA" sem="Organic_compound_other">CsA</term> does not interfere with the synthesis of <term id="T26" lex="Rel_protein" sem="Protein_family_or_group">Rel proteins</term>, but prevents the inducible degradation of <term id="T27" lex="cytosolic_NF-kappa_B_inhibitor" sem="Protein_family_or_group">cytosolic <term id="T28" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> inhibitors</term> <term id="T29" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term> and <term id="T30" lex="I_kappa_B_beta" sem="Protein_molecule">I kappa B beta</term> upon <term id="T31" lex="T_cell_activation" sem="Other"><term id="A2" sem="Cell_natural">T cell</term> activation</term>.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E29">
<type class="Negative_regulation"/>
<theme idref="E30"/>
<cause idref="T25"/>
<clue>CsA does <cluePolarity>not</cluePolarity> <clueType>interfere</clueType> <linkTheme>with</linkTheme> the synthesis of Rel proteins, but prevents the inducible degradation of cytosolic NF-kappa B inhibitors I kappa B alpha and I kappa B beta upon T cell activation.</clue>
</event>
<event id="E30">
<type class="Gene_expression"/>
<theme idref="T26"/>
<clue>CsA does not interfere with the <clueType>synthesis</clueType> <linkTheme>of</linkTheme> Rel proteins, but prevents the inducible degradation of cytosolic NF-kappa B inhibitors I kappa B alpha and I kappa B beta upon T cell activation.</clue>
</event>
<event id="E31">
<type class="Negative_regulation"/>
<theme idref="E33"/>
<cause idref="T25"/>
<clue>CsA does not interfere with the synthesis of Rel proteins, but <clueType>prevents</clueType> the inducible degradation of cytosolic NF-kappa B inhibitors I kappa B alpha and I kappa B beta upon T cell activation.</clue>
</event>
<event id="E32">
<type class="Negative_regulation"/>
<theme idref="E34"/>
<cause idref="T25"/>
<clue>CsA does not interfere with the synthesis of Rel proteins, but <clueType>prevents</clueType> the inducible degradation of cytosolic NF-kappa B inhibitors I kappa B alpha and I kappa B beta upon T cell activation.</clue>
</event>
<event KT="Other" id="E33">
<type class="Protein_catabolism"/>
<theme idref="T29"/>
<clue>CsA does not interfere with the synthesis of Rel proteins, but prevents the inducible <clueType>degradation</clueType> <linkTheme>of</linkTheme> <clueLoc>cytosolic</clueLoc> NF-kappa B inhibitors I kappa B alpha and I kappa B beta upon T cell activation.</clue>
</event>
<event KT="Other" id="E34">
<type class="Protein_catabolism"/>
<theme idref="T30"/>
<clue>CsA does not interfere with the synthesis of Rel proteins, but prevents the inducible <clueType>degradation</clueType> <linkTheme>of</linkTheme> <clueLoc>cytosolic</clueLoc> NF-kappa B inhibitors I kappa B alpha and I kappa B beta upon T cell activation.</clue>
</event>
<event KT="Other" id="E47">
<type class="Positive_regulation"/>
<theme idref="E33"/>
<cause idref="E35"/>
<clue>CsA does not interfere with the synthesis of Rel proteins, but prevents the <clueType>inducible</clueType> degradation of cytosolic NF-kappa B inhibitors I kappa B alpha and I kappa B beta <linkCause>upon</linkCause> T cell activation.</clue>
</event>
<event KT="Other" id="E48">
<type class="Positive_regulation"/>
<theme idref="E34"/>
<cause idref="E35"/>
<clue>CsA does not interfere with the synthesis of Rel proteins, but prevents the <clueType>inducible</clueType> degradation of cytosolic NF-kappa B inhibitors I kappa B alpha and I kappa B beta <linkCause>upon</linkCause> T cell activation.</clue>
</event>
<event KT="Other" id="E35">
<type class="Physiological_process"/>
<theme idref="A2"/>
<clue>CsA does not interfere with the synthesis of Rel proteins, but prevents the inducible degradation of cytosolic NF-kappa B inhibitors I kappa B alpha and I kappa B beta upon T cell <clueType>activation</clueType>.</clue>
</event>
<sentence id="S6"><term id="T32" lex="CsA" sem="Organic_compound_other">CsA</term> neither inhibits the processing of the <term id="T33" lex="NF-kappa_B1_precursor" sem="Protein_molecule">NF-kappa B1 precursor</term> <term id="T34" lex="p105" sem="Protein_molecule">p105</term> to <term id="T35" lex="p50" sem="Protein_molecule">p50</term>, nor does it &quot;stabilize&quot; the C-terminal portion of <term id="T36" lex="p105" sem="Protein_molecule">p105</term>, <term id="T37" lex="I_kappa_B_gamma" sem="Protein_molecule">I kappa B gamma</term>, which is degraded during <term id="T38" lex="p105" sem="Protein_molecule">p105</term> processing to <term id="T39" lex="mature_p50" sem="Protein_molecule">mature <term id="T40" lex="p50" sem="Protein_molecule">p50</term></term>.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E36">
<type class="Negative_regulation"/>
<theme idref="E37"/>
<cause idref="T32"/>
<clue>CsA <cluePolarity>neither</cluePolarity> <clueType>inhibits</clueType> the processing of the NF-kappa B1 precursor p105 to p50, nor does it &quot;stabilize&quot; the C-terminal portion of p105, I kappa B gamma, which is degraded during p105 processing to mature p50.</clue>
</event>
<event id="E37">
<type class="Protein_processing"/>
<theme idref="T34"/>
<product idref="T35"/>
<clue>CsA neither inhibits the <clueType>processing</clueType> <linkTheme>of</linkTheme> the <corefTheme>NF-kappa B1 precursor</corefTheme> p105 to p50, nor does it &quot;stabilize&quot; the C-terminal portion of p105, I kappa B gamma, which is degraded during p105 processing to mature p50.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E38">
<type class="Negative_regulation"/>
<theme idref="E39"/>
<cause idref="T32"/>
<clue>CsA neither inhibits the processing of the NF-kappa B1 precursor p105 to p50, <cluePolarity>nor</cluePolarity> does <corefCause>it</corefCause> <clueType>&quot;stabilize&quot;</clueType> the C-terminal portion of p105, I kappa B gamma, which is degraded during p105 processing to mature p50.</clue>
<comment>CAUTION: &quot;stabilize&quot; = inhibition of Protein_catabolism</comment></event>
<event id="E39">
<type class="Protein_catabolism"/>
<theme idref="T37"/>
<clue>CsA neither inhibits the processing of the NF-kappa B1 precursor p105 to p50, nor does it &quot;stabilize&quot; the <corefTheme>C-terminal portion of p105</corefTheme>, I kappa B gamma, which is <clueType>degraded</clueType> <clueTime>during p105 processing to mature p50</clueTime>.</clue>
</event>
<event id="E40">
<type class="Protein_processing"/>
<theme idref="T38"/>
<product idref="T39"/>
<clue>CsA neither inhibits the processing of the NF-kappa B1 precursor p105 to p50, nor does it &quot;stabilize&quot; the C-terminal portion of p105, I kappa B gamma, which is degraded during p105 <clueType>processing</clueType> to mature p50.</clue>
</event>
<sentence id="S7">These results indicate that <term id="T41" lex="CsA" sem="Organic_compound_other">CsA</term> interferes with a specific event in the <term id="T48" sem="Other">signal</term>-induced <term id="T42" sem="Other">degradation</term> of <term id="T43" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term> and <term id="T44" lex="I_kappa_B_beta" sem="Protein_molecule">I kappa B beta</term>, but does not affect the processing of <term id="T45" lex="NF-kappa_B1/p105" sem="Protein_molecule"><term id="A20" sem="Protein_molecule">NF-kappa B1</term>/<term id="T46" lex="p105" sem="Protein_molecule">p105</term></term> to <term id="T47" lex="p50" sem="Protein_molecule">p50</term>.</sentence>
<event CL="L2" KT="Analysis" id="E41">
<type class="Negative_regulation"/>
<theme idref="E43"/>
<cause idref="T41"/>
<clue>These results <clueKT><clueCL>indicate</clueCL></clueKT> that CsA <clueType>interferes</clueType> <linkTheme>with</linkTheme> a specific event in the signal-induced degradation of I kappa B alpha and I kappa B beta, but does not affect the processing of NF-kappa B1/p105 to p50.</clue>
</event>
<event CL="L2" KT="Analysis" id="E42">
<type class="Negative_regulation"/>
<theme idref="E44"/>
<cause idref="T41"/>
<clue>These results <clueKT><clueCL>indicate</clueCL></clueKT> that CsA <clueType>interferes</clueType> <linkTheme>with</linkTheme> a specific event in the signal-induced degradation of I kappa B alpha and I kappa B beta, but does not affect the processing of NF-kappa B1/p105 to p50.</clue>
</event>
<event KT="Other" id="E43">
<type class="Protein_catabolism"/>
<theme idref="T43"/>
<clue>These results indicate that CsA interferes with a specific event in the signal-induced <clueType>degradation</clueType> <linkTheme>of</linkTheme> I kappa B alpha and I kappa B beta, but does not affect the processing of NF-kappa B1/p105 to p50.</clue>
</event>
<event KT="Other" id="E44">
<type class="Protein_catabolism"/>
<theme idref="T44"/>
<clue>These results indicate that CsA interferes with a specific event in the signal-induced <clueType>degradation</clueType> <linkTheme>of</linkTheme> I kappa B alpha and I kappa B beta, but does not affect the processing of NF-kappa B1/p105 to p50.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E45">
<type class="Regulation"/>
<theme idref="E46"/>
<cause idref="T41"/>
<clue>These results <clueKT><clueCL>indicate</clueCL></clueKT> that CsA interferes with a specific event in the signal-induced degradation of I kappa B alpha and I kappa B beta, but does <cluePolarity>not</cluePolarity> <clueType>affect</clueType> the processing of NF-kappa B1/p105 to p50.</clue>
</event>
<event KT="Other" id="E46">
<type class="Protein_processing"/>
<theme idref="A20" idref1="T46"/>
<product idref="A20" idref1="T47"/>
<clue>These results indicate that CsA interferes with a specific event in the signal-induced degradation of I kappa B alpha and I kappa B beta, but does not affect the <clueType>processing</clueType> <linkTheme>of</linkTheme> NF-kappa B1/p105 to p50.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
